kidney

Novartis IgAN data in New England Journal of Medicine show Fabhalta slowed kidney function decline by 49.3%

“Persistent kidney inflammation is a hallmark of IgAN, and a key driver of disease progression, leading to ongoing kidney damage…

1 week ago

Manipal Hospital Yeshwanthpur Celebrates 50+ ABO-Incompatible and 500+ Kidney Transplants on World Kidney Day 2026

BENGALURU, India, March 21, 2026 /PRNewswire/ -- Kidney diseases are increasingly being recognised as a global health challenge, affecting millions…

2 weeks ago

Manipal Hospital Varthur Road Celebrates World Kidney Day 2026 by Honouring ‘Kidney Champions’

BENGALURU, India, March 18, 2026 /PRNewswire/ -- Manipal Hospital, Varthur Road marked World Kidney Day 2026 with an inspiring community…

3 weeks ago

KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025

RIYADH, Saudi Arabia, March 13, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) achieved a global…

3 weeks ago

Thermobalancing therapy emerges as drug-free option for BPH, chronic prostatitis, back pain and kidney stones

Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions,…

1 month ago

A Mother’s Gift of Life: Successful Living-Donor Kidney Transplant Restores Hope for 32 Years old Young CKD Patient from Bangladesh

HYDERABAD, India, Nov. 24, 2025 /PRNewswire/ -- In an inspiring story of resilience, medical excellence, and a mother's unconditional love,…

4 months ago

Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025

– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week – – Pivotal Phase 3 Launch-HTN trial featured in the…

5 months ago

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

October 17, 2025 16:05 ET  | Source: Jade Biosciences Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding…

6 months ago

Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease

MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company developing OPT101 as an innovative…

7 months ago

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…

10 months ago